Cluster 713: fgfr inhibitor selective fgf prior receipt treatment amplification alterations tumor 
Cluster 755: gene therapy prior product idh modified mutation amplification treatment tumor 
Cluster 2435: laboratory clia improvement certified clinical amendments mutation act results tumor 
